Overview
Henrik Lilljebjorn practices in Lund, Sweden. Mr. Lilljebjorn is rated as an Experienced expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Chronic Myelogenous Leukemia (CML).
His clinical research consists of co-authoring 53 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of WT1-Related Wilms Tumor Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Mr. Lilljebjorn isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Lilljebjorn isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMr. Lilljebjorn isAdvanced. Learn about Leukemia.
- Experienced
- Burkitt LymphomaMr. Lilljebjorn isExperienced. Learn about Burkitt Lymphoma.
- Chronic Myelogenous Leukemia (CML)Mr. Lilljebjorn isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Glycogen Storage Disease Type 6Mr. Lilljebjorn isExperienced. Learn about Glycogen Storage Disease Type 6.
- WT1-Related Wilms Tumor SyndromesMr. Lilljebjorn isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.